Patients who use the device and are exposed to battery fluid and extreme heat are at risk of serious injury or death from an explosion or fire, the FDA said Nov. 16.
The devicemaker recalled all serial numbers for its device, Omnipod DASH Insulin Management System Personal Diabetes Manager, which were distributed between July 2018 and August 2022. In mid-October, Insulet sent medical device correction letters about the issue, which cited an “increased risk of malfunction if [Omnipod DASH was] overcharged beyond the maximum battery voltage.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
